97 results on '"Lianidou, Evi S."'
Search Results
2. Data from Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells
3. Supplementary Table 1 from Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells
4. Supplementary Table 1 from Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells
5. Data from Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells
6. Development and Analytical Validation of a One-Step Five-Plex RT-ddPCR Assay for the Quantification of SARS-CoV-2 Transcripts in Clinical Samples
7. Molecular Assays for the Detection and Molecular Characterization of CTCs
8. The value proposition of integrative diagnostics for (early) detection of cancer. On behalf of the EFLM interdisciplinary Task and Finish Group “CNAPS/CTC for early detection of cancer”
9. SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions
10. The Role of CTCs as Tumor Biomarkers
11. Epigenetics and Biomarkers in Lung Cancer: Emerging Blood-Based Molecular Biomarkers for Detection and Monitoring
12. Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
13. USP44 Promoter Methylation in Plasma Cell-Free DNA in Prostate Cancer
14. A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer
15. Epigenetics and Biomarkers in Lung Cancer: Emerging Blood-Based Molecular Biomarkers for Detection and Monitoring
16. Circulating Tumor Cells: A Noninvasive Liquid Biopsy in Cancer
17. Molecular Assays for the Detection and Characterization of CTCs
18. RNA-Based CTC Analysis Provides Prognostic Information in Metastatic Breast Cancer
19. Analytical methodologies for the detection of SARS-CoV-2 in wastewater: Protocols and future perspectives
20. Prognostic significance of a combined gene expression analysis in EpCAM(+) CTCs in metastatic breast cancer based on a long follow-up
21. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients
22. Abstract 2290: Expression pattern of androgen receptor (AR), splice variant 7 (AR-V7) and splice variant 567 (AR-567) in circulating tumor cells and paired plasma-derived exosomes in metastatic castration resistant prostate cancer
23. Abstract 2241: Molecular characterization of circulating tumor cells in head and neck squamous cell carcinoma: Direct comparison of a label-independent size-based microfluidic device with EpCAM-based CTC enrichment
24. Abstract 2241: Molecular characterization of circulating tumor cells in head and neck squamous cell carcinoma: Direct comparison of a label-independent size-based microfluidic device with EpCAM-based CTC enrichment
25. Abstract 2290: Expression pattern of androgen receptor (AR), splice variant 7 (AR-V7) and splice variant 567 (AR-567) in circulating tumor cells and paired plasma-derived exosomes in metastatic castration resistant prostate cancer
26. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes
27. Development and Validation of Multiplex Liquid Bead Array Assay for the Simultaneous Expression of 14 Genes in Circulating Tumor Cells
28. ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
29. Abstract 4577: ESR1 methylation: A liquid biopsy-based epigenetic assay for the follow up of patients with metastatic breast cancer receiving endocrine treatment
30. Abstract 3655: DNA methylation analysis in liquid biopsy: A detailed study on quality control, sample storage and whole genome amplification procedures for downstream applications
31. Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients
32. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
33. Abstract 5691: ESR1 methylation in plasma cfDNA of patients with high-grade serous ovarian cancer
34. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
35. Exosomes: A Cancer Theranostics Road Map
36. Abstract 501: PD-L1 expressing circulating tumor cells (CTCs) in patients with breast cancer
37. Abstract 4960: Molecular characterization of in-vivo isolated EpCAM-positive circulating tumor cells in high-risk prostate cancer patients
38. Abstract 497: PIK3CA mutational status in circulating tumor cells (CTCs) and corresponding circulating tumor DNA in breast cancer patients
39. Abstract 442: RASSF1A gene promoter methylation in primary tumors, adjacent morphologically normal tissues and plasma samples of patients with high grade serous ovarian cancer
40. Abstract 499: ESR1 methylation in circulating tumor cells of patients with breast cancer
41. Gene expression profiling and DNA methylation analyses of CTCs
42. Abstract 5187: Expression of metastasis-related miRNAs in EpCAM-positive CTC fraction in corresponding plasma and FFPEs of breast cancer patients with verified metastasis
43. Abstract 3822: SOX17 gene promoter methylation in high-grade serous epithelial ovarian cancer
44. Abstract 373: Analytical and clinical validation of an EpCAM-independent assay for CTC detection in peripheral blood of early breast cancer patients based on Cytokeratin-19 (CK-19) RT-qPCR
45. MicroRNA signatures as clinical biomarkers in lung cancer
46. Molecular Characterization of Circulating Tumor Cells: Holy Grail for Personalized Cancer Treatment?
47. Abstract 4018: Development and analytical validation of a novel real-time multiplex RT-qPCR assay for the simultaneous quantification of ER, PR, HER-2 and EGFR mRNA expression in circulating tumor cells of breast cancer patients
48. Circulating tumor cells as promising novel biomarkers in solid cancers
49. Circulating Tumor Cell Isolation: A Marathon Race Worth Running
50. Advances in circulating tumor cells (ACTC): from basic research to clinical practice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.